Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.

Doximity stock has fallen during the software stock bust in 2026. The business is doing well, is highly profitable, and has a lock on the doctor social media market in the United States.

The Motley Fool • Feb 23, 2026

Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your rights

GlobeNewsWire • Feb 12, 2026

Doximity: Growth Outlook Is Murky

Doximity remains a Hold as growth visibility weakens and NRR declines to 112%, raising concerns over future expansion. Engagement and profitability are robust, with workflow tools reaching 720,000 unique prescribers and GAAP gross margin near 90%. DOCS boasts a strong balance sheet, $735 million in cash, no debt, and ongoing share repurchases, supporting downside protection.

Seeking Alpha • Feb 12, 2026

William Blair Dumps $21 Million of Healthcare Platform Doximity Stock

William Blair sold 372,184 shares of Doximity; estimated trade size was $20.89 million (quarterly average pricing). Quarter-end Doximity position value fell by $184.77 million, reflecting both trading and price changes.

The Motley Fool • Feb 9, 2026

Why Doximity Stock Plummeted Today

Doximity's sales growth slowed to 10% in Q3, and its net income dipped. Worse yet, the company guided for sales growth of only 4% in the upcoming quarter.

The Motley Fool • Feb 6, 2026

Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates

DOCS beats Q3 EPS and revenue estimates, but shares plunge 38.5% after hours as margins contract and FY26 revenue guidance is lowered.

Zacks Investment Research • Feb 6, 2026

Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript

Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript

Seeking Alpha • Feb 6, 2026

Doximity Announces Fiscal 2026 Third Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025. “We're proud to deliver another quarter of strong profits and record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. “Our newsfeed had more than 1 million quarterly active prescribers, our workflow products had 720,000 (a record QoQ jump), and our nascent AI products had over 30.

Business Wire • Feb 5, 2026

Doximity Stock Is Collapsing After Hours: Here's Why

Doximity, which operates an online networking service for medical professionals, reported third-quarter revenue of $185.05 million, beating estimates of $182.20 million, according to Benzinga Pro. Revenue was up 10% on a year-over-year basis.

Benzinga • Feb 5, 2026

Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates

Doximity (DOCS) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.45 per share a year ago.

Zacks Investment Research • Feb 5, 2026